Takeda Canada Reports Market Authorization For FRUZAQLA In Canada - Quick Facts
Takeda Canada said Health Canada has provided market authorization for FRUZAQLA, indicated for the treatment of adult patients with ...
Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC)
CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that Health Canada has provided market authorization for ...
FiercePharma4d
JPM25: Takeda spotlights 6 pipeline assets that could pull down up to $20B in collective peak sales
Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda ...
FiercePharma3d
Fierce Pharma Asia—AbbVie's $1B pact with Simcere; Takeda's launch map; Samsung Bio's growth plans
As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...
Takeda opens Bengaluru ICC, targets 750 employees to boost India presence
The flagship ICC in Bengaluru complements Takeda's existing centres in Slovakia and Mexico, highlighting its strategic focus ...
Computer Weekly3d
Takeda opens innovation centre in Bengaluru
Global biopharmaceutical giant Takeda opens its first Asian Innovation Capability Centre in Bengaluru to speed up drug ...
Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talent
Takeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, ...
Takeda to Hire Hundreds of Digital Experts in Bengaluru with the Launch of New Innovation Center
News: Takeda Innovation Capability Center to create over 750 jobs, significantly enhancing Bengaluru's global innovation ecosystem and digital expertise.